Home LiteratureArticle Details
PMID: 23622250 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.

Cell ·Vol. 153 ·No. 3 ·2013-04-25 ·Pages 707-20

Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T, Tran L, Dobrin R, Fluder E, Clurman B, Melquist S, Narayanan M, Suver C, Shah H, Mahajan M, Gillis T, Mysore J, MacDonald ME, Lamb JR, Bennett DA, Molony C, Stone DJ, Gudnason V, Myers AJ, Schadt EE, Neumann H, Zhu J, Emilsson V

Abstract

The genetics of complex disease produce alterations in the molecular interactions of cellular pathways whose collective effect may become clear through the organized structure of molecular networks. To characterize molecular systems associated with late-onset Alzheimer's disease (LOAD), we constructed gene-regulatory networks in 1,647 postmortem brain tissues from LOAD patients and nondemented subjects, and we demonstrate that LOAD reconfigures specific portions of the molecular interaction structure. Through an integrative network-based approach, we rank-ordered these network structures for relevance to LOAD pathology, highlighting an immune- and microglia-specific module that is dominated by genes involved in pathogen phagocytosis, contains TYROBP as a key regulator, and is upregulated in LOAD. Mouse microglia cells overexpressing intact or truncated TYROBP revealed expression changes that significantly overlapped the human brain TYROBP network. Thus the causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.

MeSH Terms
Adaptor Proteins, Signal Transducing/metabolism Alzheimer Disease/genetics,metabolism Animals Bayes Theorem Brain/metabolism,pathology Gene Regulatory Networks Humans Membrane Proteins/metabolism Mice Microglia/metabolism
Chemicals
Adaptor Proteins, Signal Transducing Membrane Proteins TYROBP protein, human
Authors & Affiliations
30 authors, click to expand affiliations / ORCID
Zhang Bin
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. bin.zhang@mssm.edu
Gaiteri Chris
Bodea Liviu-Gabriel
Wang Zhi
McElwee Joshua
Podtelezhnikov Alexei A
Zhang Chunsheng
Xie Tao
Tran Linh
Dobrin Radu
Fluder Eugene
Clurman Bruce
Melquist Stacey
Narayanan Manikandan
Suver Christine
Shah Hardik
Mahajan Milind
Gillis Tammy
Mysore Jayalakshmi
MacDonald Marcy E
Lamb John R
Bennett David A
Molony Cliona
Stone David J
Gudnason Vilmundur
Myers Amanda J
Schadt Eric E
Neumann Harald
Zhu Jun
Emilsson Valur
References (42)
42 references, click to expand
  1. Genetics of gene expression and its effect on disease.
    Nature. 2008 Mar 27;452(7186):423-8 PMID: 18344981
  2. Vascular risk factors and Alzheimer's disease.
    Expert Rev Neurother. 2008 May;8(5):743-50 PMID: 18457531
  3. Neuropathological stageing of Alzheimer-related changes.
    Acta Neuropathol. 1991;82(4):239-59 PMID: 1759558
  4. Variations in DNA elucidate molecular networks that cause disease.
    Nature. 2008 Mar 27;452(7186):429-35 PMID: 18344982
  5. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
    J Leukoc Biol. 2006 Mar;79(3):596-610 PMID: 16365156
  6. Immunotherapy for Alzheimer's disease.
    Lancet Neurol. 2003 Apr;2(4):215-20 PMID: 12849209
  7. TREM2 variants in Alzheimer's disease.
    N Engl J Med. 2013 Jan 10;368(2):117-27 PMID: 23150934
  8. A general framework for weighted gene co-expression network analysis.
    Stat Appl Genet Mol Biol. 2005;4:Article17 PMID: 16646834
  9. Molecular networks as sensors and drivers of common human diseases.
    Nature. 2009 Sep 10;461(7261):218-23 PMID: 19741703
  10. The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
    Mech Ageing Dev. 2005 Oct;126(10):1019-25 PMID: 15936057
  11. Inflammation, microglia, and Alzheimer's disease.
    Neurobiol Dis. 2010 Mar;37(3):503-9 PMID: 19833208
  12. Genetic control of human brain transcript expression in Alzheimer disease.
    Am J Hum Genet. 2009 Apr;84(4):445-58 PMID: 19361613
  13. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.
    J Clin Invest. 1985 Oct;76(4):1501-13 PMID: 3932467
  14. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
    Eur J Pharmacol. 2008 May 6;585(1):119-29 PMID: 18384771
  15. Functional organization of the transcriptome in human brain.
    Nat Neurosci. 2008 Nov;11(11):1271-82 PMID: 18849986
  16. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
    Nature. 2012 Aug 2;488(7409):96-9 PMID: 22801501
  17. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.
    Cell Stem Cell. 2009 Dec 4;5(6):634-45 PMID: 19951691
  18. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.
    Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10726-31 PMID: 15247418
  19. A network view of disease and compound screening.
    Nat Rev Drug Discov. 2009 Apr;8(4):286-95 PMID: 19337271
  20. Oxidative stress in the progression of Alzheimer disease in the frontal cortex.
    J Neuropathol Exp Neurol. 2010 Feb;69(2):155-67 PMID: 20084018
  21. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
    Nature. 2008 Feb 7;451(7179):720-4 PMID: 18256671
  22. The genetics of Alzheimer disease: back to the future.
    Neuron. 2010 Oct 21;68(2):270-81 PMID: 20955934
  23. Nasu-Hakola disease and primary microglial dysfunction.
    Nat Rev Neurol. 2010 Sep;6(9):2 p following 523 PMID: 20836191
  24. Vascular and metabolic dysfunction in Alzheimer's disease: a review.
    Exp Biol Med (Maywood). 2011 Jul;236(7):772-82 PMID: 21680755
  25. Forecasting the global burden of Alzheimer's disease.
    Alzheimers Dement. 2007 Jul;3(3):186-91 PMID: 19595937
  26. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology.
    Brain Pathol. 2012 Jul;22(4):547-61 PMID: 22126211
  27. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Science. 1993 Aug 13;261(5123):921-3 PMID: 8346443
  28. Characterization of the proteome, diseases and evolution of the human postsynaptic density.
    Nat Neurosci. 2011 Jan;14(1):19-21 PMID: 21170055
  29. Failure is an option: learning from unsuccessful proof-of-concept trials.
    Drug Discov Today. 2008 Nov;13(21-22):913-6 PMID: 18954804
  30. Huntington's disease: seeing the pathogenic process through a genetic lens.
    Trends Biochem Sci. 2006 Sep;31(9):533-40 PMID: 16829072
  31. Alzheimer mechanisms and therapeutic strategies.
    Cell. 2012 Mar 16;148(6):1204-22 PMID: 22424230
  32. Microglia in neurodegenerative disease.
    Nat Rev Neurol. 2010 Apr;6(4):193-201 PMID: 20234358
  33. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.
    BMJ. 2003 Jul 19;327(7407):128 PMID: 12869452
  34. Variant of TREM2 associated with the risk of Alzheimer's disease.
    N Engl J Med. 2013 Jan 10;368(2):107-16 PMID: 23150908
  35. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas.
    Mol Syst Biol. 2008;4:169 PMID: 18277385
  36. TopHat: discovering splice junctions with RNA-Seq.
    Bioinformatics. 2009 May 1;25(9):1105-11 PMID: 19289445
  37. Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients.
    PLoS One. 2009 Jul 16;4(7):e6264 PMID: 19606219
  38. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease.
    Neurobiol Aging. 2002 May-Jun;23(3):397-404 PMID: 11959402
  39. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
    Cell. 1993 Mar 26;72(6):971-83 PMID: 8458085
  40. Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention.
    J Alzheimers Dis. 2010;20(3):689-97 PMID: 20182015
  41. Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease.
    Genome Biol. 2009;10(5):R55 PMID: 19463160
  42. Genetic insights in Alzheimer's disease.
    Lancet Neurol. 2013 Jan;12(1):92-104 PMID: 23237904
Article Info
Journal
Cell
Abbr.
Cell
ISSN
1097-4172
Published
2013-04-25
Pages
707-20
Language
English
Region
United States
NLM ID
0413066
PMCID
PMC3677161
Subset
IM
Grants
NIA NIH HHS · R01 AG17917 · United States
NIA NIH HHS · R01 AG030146 · United States
NIA NIH HHS · R01 AG017917 · United States
NIA NIH HHS · P30 AG10161 · United States
NIMH NIH HHS · R01 MH097276 · United States
NIA NIH HHS · R01 AG034504 · United States
NINDS NIH HHS · R01 NS032765 · United States
NIA NIH HHS · R01 AG011101 · United States
NIA NIH HHS · R01 AG015819 · United States
NIA NIH HHS · K08 AG034290 · United States
NINDS NIH HHS · NS032765 · United States
NIA NIH HHS · R01 AG15819 · United States
NIA NIH HHS · R01 AG11101 · United States
NIA NIH HHS · P30 AG010161 · United States
Databases
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com